Assistance Publique – Hôpitaux de Paris Inks Partnership with IQVIA for a ‘Prime Site’ in Europe

Jan 25, 2020 | Assistance Publique – Hôpitaux de Paris, Clinical Investigational Site, Clinical Research Site, Europe, IQVIA

Assistance Publique – Hôpitaux de Paris Inks Partnership with IQVIA for a ‘Prime Site’ in Europe

One of Europe’s leading clinical research centers, Assistance Publique – Hôpitaux de Paris (AP-HP), has joined forces with IQVIA, the global health technology, and human data science company to launch the Paris Prime Site for clinical trials. This AP-HP partnership represents IQVIA’s second Prime Site within France, as well as the 43rd globally, the 18th within Europe, and the largest research facility of its kind within that region.

Strategic Partnerships for Competitive Differentiation

IQVIA’s clinical research outsourcing business line (former Quintiles), benefits competitively as they can articulate to industry sponsors in Europe that their ability to offer premier research site services is more layered and comprehensive than others. IQVIA will staff this AP-HP (including a Prime Site manager), will oversee partnership relations, and follow up on the delivery of IQVIA research projects. Key themes the AP-HP will help with include 1) collaboration on a research program for ongoing process optimization, 2) reduction in the time to start clinical research, 3) align procedures and scalable support for complex clinical trials, and 4) real-world evidence studies within France and Europe.          

An Elite Investigational Site in Europe

In 2018 alone, AP-HP conducted more than 4,000 research projects, including 1,850 sponsored by industry and 1,240 sponsored by AP-HP. The GHU AP-HP Nord is well-known for the following fields: neuroscience, hematology, immunology, oncology, dermatology, gastrointestinal diseases, infectious diseases, inflammatory and renal transplantation diseases, cardiovascular diseases, imaging, and emergency care.

Promoting European Sites

The parties declared in their press release that the alliance affords Europe’s largest university hospitals at an international level, particularly among biotech companies specializing in biotechnology across North America and Asia.

AP-HP Background

AP-HP is the largest hospital system in Europe, and one of the largest in the world. It provides health care, teaching, research, prevention, education, and emergency medical services in 52 branches of medicine. It employs more than 90,000 people (including 15,800 physicians) in 44 hospitals and receives more than 5.8 million annual visits.

Linked to the University of Paris and its seven colleges of medicine, two of odontology and two of pharmacy, it is organized in several hospitals’ local trusts, each associated with a faculty to other integrative care to its population.

AP-HP Comment

Florence Favrel-Feuillade, director of the Delegation for Clinical Research and Innovation, AP-HP, said, “The partnership between AP-HP and IQVIA is a strong signal of AP-HP’s willingness to position itself as one of the world’s leading reference centers for clinical investigation, particularly to enable patients to benefit from the most innovative treatments.”

Contact

Florence Favrel-Feuillade, director of the Delegation for Clinical Research and Innovation

Call to Action. For more information see the following link

0 Comments